Journals / Türk Nöroloji Dergisi / 2006 / Cilt: 12 - Sayı: 5

Tumefactive multiple sclerosis: Case report and review of the literature

Tümefaktif multipl skleroz: Olgu sunumu ve literatürün gözden geçirilmesi

Pages
391–397
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The clinical significance of these large plaques should be revealed through more comprehensive studies to be conducted.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ABSTRACT Tumefactive Multiple Sclerosis: Case Report and Review of the Literature Scientific background: Tumefactive multiple sclerosis (MS) is a rare variant ofb MS.
📊
Key Findings & Data:Contrary to the limited literature findings, the relatively good prognosis identified in the present case with such a lesion has been found to be significant.
💡
Conclusion & Impact:The clinical significance of these large plaques should be revealed through more comprehensive studies to be conducted.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

ABSTRACT Tumefactive Multiple Sclerosis: Case Report and Review of the Literature Scientific background: Tumefactive multiple sclerosis (MS) is a rare variant ofb MS. It has been reported that this disorder characterized by large, demiyelinating lesions has displayed a monophasic course or subsequently it could develop into typical MS. However, in some patients with MS, tumefactive demiyelinating lesions could be encountered during the course of the disease. In such cases, other demiyelinating disease, MS variants, primary central nervous system vasculitis, glioma or other neoplasms should also be taken into consideration in differential diagnosis. In the diagnosis of such large lesions, physiologic magnetic resonance imaging (MR!) investigations have also been recommended as an alternative to brain biopsy in recent-years. Although the disease has been reported to display an aggressive course in some limited MS cases in whom new-onset attack characterized by tumefactive lesion is present, the effect of these large lesions on the prognosis of MS patients have not conclusively been identified. Objective: To report the case of a forty-year-old female whose tumefactive MS plaque has been identified in the acute attack characterized by behavior and personality changes with a diagnosis of relapsing-remitting MS (RRMS) and compare the obtained data with' the literature findings. Material and methods: Routine neurological examination and biochemical investigations, infectious and collagen vascular disease tests, evoked potential studies, cerebrospinal fluid examination, oligoclonal band analysis, conventional MRI and diffusion weighted MRI methods were performed. Results: Tumefactive demiyelinating lesion has been identified in a case with a diagnosis of RRMS and, radiological and clinical improvement was observed by means of pulse steroid treatment. Conclusions: Tumefactive lesions may develop in typical RRMS cases during the course of the disease and physiologic MRI methods have been observed to be useful in the diagnosis of these lesions. Contrary to the limited literature findings, the relatively good prognosis identified in the present case with such a lesion has been found to be significant. The clinical significance of these large plaques should be revealed through more comprehensive studies to be conducted.

Özet

Bilimsel zemin: Tümefaktif multipl skleroz (MS), MS'in nadir görülen bir varyantıdır. Geniş, demiyelinizan lezyonlarla karakterize olan bu tablonunmonofazik seyjr-gösterdiği veya sonradan tipik MS'e dönüşebildiği bildirilmiştir. Bununja birlikte bazı MS'li olgularda hastalığın seyri sırasında tümefaktif demiyelinizan lezyonlara rastlanılabilir. Bu durumlarda ayırıcı tanıda diğer demiyelinizan hastalıklar, MS varyantları, primer santral sinir sistemi vasküliti ile glioma ve diğer tümörler de düşünülmelidir. Bu tip geniş lezyonların tanısında son dönemde beyin biyopsisine alternatif olarak fizyolojik manyetik rezonans görüntüleme (MRG) incelemeleri de önerilmektedir. Tümefaktif lezyonla karakterize, yeni atağının olduğu gösterilmiş sınırlı sayıdaki MS olgusunda, hastalık seyrinin agresif bir süreç izlediği bildirilmesine karşın bu geniş lezyonların MS hastalarında, prognoz üzerindeki etkisi tam belirlenememiştir. Amaç: Relapsing-remitting MS (RRMS) tanısıyla takipte iken kişilik ve davranış değişikliği ile karakterize yeni atak bulguları olan ve MRG'de tümefaktif MS plağı saptanan 40 yaşındaki kadın olguyu bildirmek ve olguyla ilgili elde edilen verileri literatür bilgileri ışığında tartışmak. Gereç ve Yöntemler: Rutin nörolojik muayene ve biyokimyasal incelemeler, enfeksiyöz ve kollajen doku testleri, uyarılmış potansiyel çalışmaları, serebrospinal sıvı incelemesi, oligokional band araştırması ve konvansiyonel MRG ile diffüzyon ağırlıklı MRG tetkikleri yapıldı. Sonuçlar: RRMS tanılı olguda tümefaktif demiyelinizan lezyon tanınmış ve pulse steroid tedavisi ile klinik ve radyolojik düzelme izlenmiştir, izlenimler: Tipik RRMS olgularında hastalığın seyri sırasında tümefaktif lezyonun gelişebildiği ve bu lezyonların tanınmasında fizyolojik MRG yöntemlerinin faydalı olduğu görülmüştür. Kısıtlı literatür bilgilerinin tersine bu tipte lezyonu saptanan olgumuzdaki göreceli iyi prognoz dikkat çekici bulunmuştur. Bu geniş plakların klinik önemi yapılacak daha kapsamlı çalışmalarla ortaya konulmalıdır.

🔖

Cite This Article

YERDELEN, D., GİRAY, S., KARAKURUM, B., KARACA, S., BENLİ, S., KARATAŞ, M. (2022). Tumefactive multiple sclerosis: Case report and review of the literature. Türk Nöroloji Dergisi, Cilt: 12 - Sayı: 5, 391–397. https://ajindex.com/articles/637163

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Youl BD, Kermode AG, Thompson AJ, Revesz T, Scaravilli F, Barnard RO, et al. Destructive lesions in demiyelinating disease. J Neurol Neurosurg Psychiatry 1991;54 (4):288-292
  2. Selkirk SM, Shi J. Relapsing-remitting tumefactive multiple sclerosis.Mult Scler2005;11:731 -734
  3. Dagher A, Smirniotopoulos J. Tumefactive demiyelinating lesions. Neuroradiology 1996;38:560-565
  4. Sagar HJ, Warlow CP, Sheldon PWE, Esiri MM. Multiple sclerosis with clinical and radiological features of cerebral tumor. J Neurol Neurosurg Psychiatry 1982;45:802-808
  5. Tan HM, Chan LL, Chuah KL, Goh NS, Tang KK. Monophasic, solitary tumefactive demiyelinating lesion: neuroimaging featuresand neuropathological diagnosis. Br J Radiol 2004;77:153-156
  6. Kepes JJ. Large focal tumor-like demiyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? Â study of 31 patients. Ann Neurol 1993;33:18-27
  7. Annesley-Williams D, Farrell MA, Staunton H, Brett FM. Acute demiyelination, neuropathological diagnosis, clinical evolution. J Neuropathol Exp Neurol 2000;59:477-489
  8. Ernst T, Chang L, Walot I, Huff K. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology 1998; 51:1486-1488
  9. Sugita Y, Terasaki M, Shigemori M, Sakata K, Morimatsu M. Acute focal demiyelinating disease simulating brain tumors: Histopathologic guidelines for an accurate diagnosis. Neuropathology 2001;21:25-31
  10. Capello E, Roccatagliata L, Pagano F, Mancardi GL. Tumor-like multiple sclerosis lesions:neuropathological clues. Neurol Sci 2001;22:113-116
  11. Green AJ, Bollen AW, Berger MS, Oksenberg JR, Hauser SL. Multiple sclerosis and oligodendroglioma. Mult Scler 2001;7 (4):269-273
  12. Tsui EY, Leung WH, Chan JH, Cheung YK, Nq SH. Tumefactive demiyelinating lesions by combined perfusion-weighted and diffusion weighted imaging. Comput Med Imaging Graph 2002;26 (5):343-346
  13. Law M, Meltzer DE, Cha S. Spectroscopic magnetic resonance imaging of a tumefactive demiyelinating lesion. Neuroradiology 2002;44(12):986-989
  14. Enzinger C, Strasser-Fuchs S, Ropele S, Kapeller P, Kleinert R, Fazekas F. Tumefactive demiyelinating lesions: conventional and advanced magnetic resonance imaging. Mult Scler 2005;11:135-139
  15. Rovaris M, Gass A, Bammer R, Hickman SJ, Ciccarelli O, Miller DH, Filippi M. Diffusion MRI in multiple sclerosis. Neurology 2005: 65:1526-1532
  16. Rashid W, Parkes LM, Ingle GT, Chard DT, Toosy AT, Altmann DR, et al. Abno